![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Astrazeneca Starts Olaparib in Phase III for Ovarian Cancer
Astrazeneca Starts Olaparib in Phase III for Ovarian Cancer
September 4, 2013
AstraZeneca has begun a Phase III trial of olaparib for BRCA-mutated ovarian cancer.
The Pharma Letter
The Pharma Letter
Upcoming Events
-
21Oct